Alexandre Sayadi

MD, MSc pathology resident @APHP, former hepatology resident. #Liverpath

[Paradis valerie @valerie_paradis]

Please scan this QR code and increase your expertise in liver pathology @EASLedu @ESP_Pathology

[The Baveno Cooperation: an EASL Consortium @BavenoCoop]

🧫 New multisociety consensus on PSVD
🗣️ L. Elkrief | #EASLCongress
🔬 PSVD & NCPF now interchangeable
⚠️ Biopsy mandatory | can be diagnosed WITHOUT portal hypertension
💡 First globally endorsed framework (EASL/AASLD/APASL/ALEH)
🔗 https://t.co/aO1PaWIuN0

[nature @Nature]

Nature research paper: A spatial atlas of the healthy human liver from live donors
https://t.co/WFP3eUGalQ

[Dina Tiniakos @DinaTiniakos]

The waiting is over! The consensus statements 🤝 of the🌍International #MASLD Pathology Group for MASH clinical trials are published @JHepatology! Good for 🔬🖥️and 🤖!@ESP_Pathology @EASLnews @AASLDtweets @UKLiverPath @my_ueg @LiverPath_HPHS @uoaofficial
https://t.co/hZuCjdRfA3

[Ramon Bataller @rabataller]

🚨 AI won’t replace doctors… but it can prevent them from learning how to think.

A critical article in @NEJM shows that if introduced too early in medical training, it weakens clinical reasoning.

✅ A good doctor will always need critical thinking.

N Engl J Med 2025;393:786

[Nature Reviews Gastroenterology & Hepatology @NatRevGastroHep]

New online! The future of pathology in gastroenterology and hepatology https://t.co/8R0yxMcwOL

[The Lancet Gastroenterology & Hepatology @LancetGastroHep]

New Review - Recompensation in decompensated cirrhosis

https://t.co/Rwl0K3WTSE

#LiverTwitter #MedTwitter

[Rautou Pierre-Emmanuel @RautouE]

📢An overview on vascular involvement in chronic liver disease:
https://t.co/XZmnFqqpFu
Everything on:
➡️ portal vein thrombosis
➡️ PSVD
➡️ haemostasis in cirrhosis
➡️ management of portal hypertension
➡️ challenges of TIPS
➡��� vascular consequences of cirrhosis (PoPH, HPS, AKI)

[Aurélie Beaufrère @A_Beaufrere]

Happy to share our last collaborative study about capillary liver neoplasms (HSVN and AH)
@valerie_paradis @fhu_mosaic @ModernPathology

https://t.co/7hNkF1Yzkx

[Rautou Pierre-Emmanuel @RautouE]

📢📢 Analysis of 249 patients with MASLD and of 2 rat models:
⚠️Liver endothelial cell (LSEC) capillarisation appears before MASH onset
❌LSEC capillarisation progresses with liver fibrosis and inflammation
✅Lanifibranor improves LSEC function

https://t.co/vjPEif7xhE

[Aurélie Beaufrère @A_Beaufrere]

Beaujon team well represented at #CarrefourPathologie2024 😉
@fhu_mosaic @criu1149 @hopitalbeaujon @valerie_paradis @cros_jerome @SayadiAlexandre @SFPathol

[Aurélie Beaufrère @A_Beaufrere]

Congratulation to @SayadiAlexandre on winning the SFP research Grant
@SFPathol

[Aurélie Beaufrère @A_Beaufrere]

@SayadiAlexandre @SFPathol Very proud to win the best oral communications award #CarrefourPathologie2024 for our work on AI prediction of transcriptomic classes in intrahepatic cholangiocarcinoma on histological slides
@SFPathol @fhu_mosaic @ThomasW04410315 @valerie_paradis @Caldera60373705 @cros_jerome

[Elizabeth McKenna @ElizSMcKenna]

Now online in @CD_AACR: TREM2-expressing Multinucleated Giant Macrophages Are a Biomarker of Good Prognosis in Head and Neck Squamous Cell Carcinoma - by @GregoireGessain @FGinhoux and colleagues https://t.co/sPoUqHubgT @GustaveRoussy

[Paradis valerie @valerie_paradis]

Congrats to talented pathologists 🙏 proud to work with you 😉

[Aurélie Beaufrère @A_Beaufrere]

Come see our posters at #ESPcongress on hepatic small vessels neoplasms and on histological predictors of response to atezo-bev in HCC biopies
@SayadiAlexandre @valerie_paradis @fhu_mosaic @hopitalbeaujon @Hopital_Bicetre

[HCC CONNECT powered by COR2ED @hccconnectinfo]

📢 Registration is open for the @EASLnews #LiverCancerSummit 2025!

🗓️ 20-22 February
📍 Paris, France

Abstract submission deadline - 12 November

Essential for staying at the forefront of liver cancer research and treatment.

Find out more👇
https://t.co/xS6CNlTqOt

#MedEd

[Nutrition Science @NutrioSci]

Genetic cholestasis in children and adults @JHepatology #Meded #MedX

https://t.co/V1uiOEo7zz

[ATS Blue Journal @ATSBlueEditor]

Diffuse Pulmonary Neuroendocrine Cell Hyperplasia with Parietal Pleural Involvement

🔗 https://t.co/dO0x3aZNJE

[Rautou Pierre-Emmanuel @RautouE]

Curious about the role of liver endothelial cells in MASLD?
Check our "News&Views" just out in @NatureCVR

https://t.co/yluc5WTUAu